Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Herrmann

Showing results (51-60 of 269) with videos related to

Pageof 27
Sort By:
European Heart Journal|January 23, 2026
The year in cardiovascular medicine 2025: the top 10 papers in cardio-oncologyJoerg Herrmann, Teresa López-Fernández, Alexander R Lyon
Frontiers in Cardiovascular Medicine|March 27, 2023
Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into playMaryam Moossavi, Xiaoguang Lu, Joerg Herrmann, et al.
Blood|November 9, 2013
Spontaneous coronary artery dissection during hematopoietic stem cell infusionMuhammed A Mir, Mrinal M Patnaik, Joerg Herrmann
Blood|November 9, 2021
How I treat cardiovascular complications in patients with lymphoid malignanciesJoerg Herrmann, Kristen B McCullough, Thomas M Habermann
European Heart Journal. Cardiovascular Pharmacotherapy|September 15, 2022
2022 ESC Guidelines on cardio-oncology: how can we improve the cardiovascular health of patients with cancer and cancer survivors?Teresa López-Fernández, Alexander R Lyon, Joerg Herrmann
International Journal of Cardiovascular Interventions|July 16, 2005
The ubiquitin-proteasome system--micro target for macro intervention?Joerg Herrmann, Aaron Ciechanover, Lilach O Lerman, et al.
Circulation|November 25, 2016
Response by Herrmann et al to Letter Regarding Article, "Vascular Toxicities of Cancer Therapies: The Old and the New-An Evolving Avenue"Joerg Herrmann, Eric H Yang, Cezar Iliescu, et al.
Cardiovascular Research|January 21, 2004
The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extendedJoerg Herrmann, Aaron Ciechanover, Lilach O Lerman, et al.
Journal of the American Society of Hypertension : JASH|April 29, 2018
Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic eventsRhian M Touyz, Sandra M S Herrmann, Joerg Herrmann
Frontiers in Cardiovascular Medicine|December 16, 2020
Cardio-Oncology: Learning From the Old, Applying to the NewJun-Ichi Abe, Syed Wamique Yusuf, Anita Deswal, et al.
Pageof 27

Showing results (51-60 of 269) with videos related to

Sort By:
Pageof 27
European Heart Journal|January 23, 2026
The year in cardiovascular medicine 2025: the top 10 papers in cardio-oncologyJoerg Herrmann, Teresa López-Fernández, Alexander R Lyon
Frontiers in Cardiovascular Medicine|March 27, 2023
Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into playMaryam Moossavi, Xiaoguang Lu, Joerg Herrmann, et al.
Blood|November 9, 2013
Spontaneous coronary artery dissection during hematopoietic stem cell infusionMuhammed A Mir, Mrinal M Patnaik, Joerg Herrmann
Blood|November 9, 2021
How I treat cardiovascular complications in patients with lymphoid malignanciesJoerg Herrmann, Kristen B McCullough, Thomas M Habermann
European Heart Journal. Cardiovascular Pharmacotherapy|September 15, 2022
2022 ESC Guidelines on cardio-oncology: how can we improve the cardiovascular health of patients with cancer and cancer survivors?Teresa López-Fernández, Alexander R Lyon, Joerg Herrmann
International Journal of Cardiovascular Interventions|July 16, 2005
The ubiquitin-proteasome system--micro target for macro intervention?Joerg Herrmann, Aaron Ciechanover, Lilach O Lerman, et al.
Circulation|November 25, 2016
Response by Herrmann et al to Letter Regarding Article, "Vascular Toxicities of Cancer Therapies: The Old and the New-An Evolving Avenue"Joerg Herrmann, Eric H Yang, Cezar Iliescu, et al.
Cardiovascular Research|January 21, 2004
The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extendedJoerg Herrmann, Aaron Ciechanover, Lilach O Lerman, et al.
Journal of the American Society of Hypertension : JASH|April 29, 2018
Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic eventsRhian M Touyz, Sandra M S Herrmann, Joerg Herrmann
Frontiers in Cardiovascular Medicine|December 16, 2020
Cardio-Oncology: Learning From the Old, Applying to the NewJun-Ichi Abe, Syed Wamique Yusuf, Anita Deswal, et al.
Pageof 27